share_log

Leerink Partners Initiates Coverage On NeuroPace With Outperform Rating, Announces Price Target of $22

Benzinga ·  Jan 30 21:15

Leerink Partners analyst Mike Kratky initiates coverage on NeuroPace (NASDAQ:NPCE) with a Outperform rating and announces Price Target of $22.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment